140 related articles for article (PubMed ID: 32445654)
1. Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway.
Lee JH; Mohan CD; Shanmugam MK; Rangappa S; Sethi G; Siveen KS; Chinnathambi A; Alahmadi TA; Alharbi SA; Basappa S; Rangappa KS; Ahn KS
Biochimie; 2020 Aug; 175():58-68. PubMed ID: 32445654
[TBL] [Abstract][Full Text] [Related]
2. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
[TBL] [Abstract][Full Text] [Related]
3. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
4. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
[TBL] [Abstract][Full Text] [Related]
5. Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway.
He JD; Wang Z; Li SP; Xu YJ; Yu Y; Ding YJ; Yu WL; Zhang RX; Zhang HM; Du HY
Oncotarget; 2016 Dec; 7(51):84520-84532. PubMed ID: 27588401
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
[TBL] [Abstract][Full Text] [Related]
7. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
[TBL] [Abstract][Full Text] [Related]
8. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.
Subramaniam A; Shanmugam MK; Perumal E; Li F; Nachiyappan A; Dai X; Swamy SN; Ahn KS; Kumar AP; Tan BK; Hui KM; Sethi G
Biochim Biophys Acta; 2013 Jan; 1835(1):46-60. PubMed ID: 23103770
[TBL] [Abstract][Full Text] [Related]
9. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
10. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
[TBL] [Abstract][Full Text] [Related]
11. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway.
Liu K; Tian T; Zheng Y; Zhou L; Dai C; Wang M; Lin S; Deng Y; Hao Q; Zhai Z; Dai Z
J Cell Mol Med; 2019 Apr; 23(4):3040-3044. PubMed ID: 30697962
[TBL] [Abstract][Full Text] [Related]
12. Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway.
Xu G; Zhu L; Wang Y; Shi Y; Gong A; Wu C
Biomed Res Int; 2017; 2017():1832494. PubMed ID: 29226125
[TBL] [Abstract][Full Text] [Related]
13. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
Li F; Fernandez PP; Rajendran P; Hui KM; Sethi G
Cancer Lett; 2010 Jun; 292(2):197-207. PubMed ID: 20053498
[TBL] [Abstract][Full Text] [Related]
14. Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death.
Xie L; Zeng Y; Dai Z; He W; Ke H; Lin Q; Chen Y; Bu J; Lin D; Zheng M
Int J Biol Sci; 2018; 14(5):577-585. PubMed ID: 29805309
[TBL] [Abstract][Full Text] [Related]
15. Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3.
Tai WT; Cheng AL; Shiau CW; Liu CY; Ko CH; Lin MW; Chen PJ; Chen KF
Mol Cancer Ther; 2012 Feb; 11(2):452-63. PubMed ID: 22180308
[TBL] [Abstract][Full Text] [Related]
16. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
[TBL] [Abstract][Full Text] [Related]
17. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity.
Ke Y; Bao T; Wu X; Tang H; Wang Y; Ge J; Fu B; Meng X; Chen L; Zhang C; Tan Y; Chen H; Guo Z; Ni F; Lei X; Shi Z; Wei D; Wang L
Biochem Biophys Res Commun; 2017 Jan; 483(1):509-515. PubMed ID: 27998773
[TBL] [Abstract][Full Text] [Related]
18. PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.
Zhang XP; Jiang YB; Zhong CQ; Ma N; Zhang EB; Zhang F; Li JJ; Deng YZ; Wang K; Xie D; Cheng SQ
Cell Physiol Biochem; 2018; 47(4):1643-1654. PubMed ID: 29945155
[TBL] [Abstract][Full Text] [Related]
19. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
Kang JH; Li MJ; Luan PP; Jiang DK; Chen YW; Xu X; Yu Q; Xu YW; Su Q; Peng WH; Jian WX
Cell Biol Int; 2020 Oct; 44(10):2053-2064. PubMed ID: 32584509
[TBL] [Abstract][Full Text] [Related]
20. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
